Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie Group Inc (DXYN), Genetic Technologies Limited (ADR) (GENE), Galecto (GLTO), ESS Tech (GWH), Trevena Inc (TRVN), and iShares S&P Develpd ex US Prprty Indx Fd (WPS).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule
- Biotech Alert: Searches spiking for these stocks today
- Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition
- Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
- Aligos Therapeutics Advances Pipeline Amid Financial Challenges